We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

Cell therapy.

Cell Therapy Treatment Effectively Treats Immune-Compromised Children

A selection of diabetes monitoring and treatment neccessities.

Siblings' Rare Genetic Mutation Offers Clues for Type 1 Diabetes Therapy

High magnification micrograph of microglia cells stained with Rio-Hortega's method (silver carbonate). This type is the ramified or resting microglia that appears in normal brain tissue.

Mobilizing Microglia in the Fight Against Alzheimer’s Disease

Immunotherapy After Kidney Cancer Surgery Improves Overall Survival

Cannabinols Show Neuroprotective Properties in Fruit Flies

Antipsychotic Use in Dementia Linked to Elevated Health Risks

News

Vapourtec Expands R-Series Capabilities

UK-based flow chemistry engineering specialists Vapourtec has extended the capabilities of its R-Series system with a new addition to its range of pump modules.

Computer Model Sets New Precedent in Drug Discovery

New computational model can precisely simulate, predict therapeutic protein behaviors to help zero in on ideal drug design candidates.

Charities Pledge to Inject Millions to Jump Start Drug Development for Brain Diseases

MRC Technology to lead Neurodegeneration Medicines Acceleration Programme to uncover promising drugs in pharma libraries.

Recipharm Acquires Lusomedicamenta for SEK 1 Billion

Limited customer overlap and significant export activities from Lusomedicamenta, will give Recipharm access to new markets and customers.

BM-S to Build Large-Scale Biologics Manufacturing Facility in Ireland

The new facility will significantly increase the company’s biologics manufacturing capacity.

Wallet-Sized Labs The Next Big Thing

RMIT researchers are developing inexpensive, portable toxicology laboratories so small you could fit them in your wallet.

Horizon Discovery Group Signs Agreement with Top Ten Pharma Company for Approximately $750,000

Horizon CombinatoRx to perform drug combination screening on a lead oncology asset.

Direct Drug Screening Of Biopsies Could Overcome Resistance

Combining genetic with pharmacologic screening of tumors may enable truly individualized treatment regimens.

Genticel Completes Procervix Phase II Study Enrollment Ahead of Schedule

A total of 239 subjects infected with HPV 16 and/or 18 enrolled at 39 clinical centers throughout Europe for RHEIA-VAC study of ProCervix.

Charge-Tagged Proline-Based Organocatalyst for Mechanistic Studies Using ESI-MS

In a comparative continous flow ESI-MS study, researchers use a new charged catalyst and neutral L-proline to investigate the proline-catalyzed inverse crossed aldol reaction of aldehydes with diethyl ketomalonate.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter